Toshiki Hyodo
Papers
1
Total Citations
2
H-Index
1
About
Toshiki Hyodo is a clinician-researcher whose work centers on the intersection of pediatric oncology and urologic pathology, with a particular focus on rare secondary malignancies following childhood cancer treatment. His most cited paper, a 2023 case report and literature review, examines a rare instance of renal cell carcinoma (RCC) with a TFE3 gene translocation arising in the contralateral kidney of a patient previously treated for childhood nephroblastoma. This work highlights a critical clinical message: while secondary RCC is uncommon, it must be considered as a potential late effect of chemoradiotherapy in pediatric cancer survivors. By documenting this case, Hyodo contributes to the growing body of evidence on treatment-related carcinogenesis and the genetic underpinnings of secondary tumors. His research underscores the importance of long-term surveillance for survivors of childhood cancers, particularly those exposed to nephrotoxic therapies. With 2 citations to date, this paper serves as a valuable reference for oncologists and pathologists navigating the complexities of secondary malignancies. Hyodo’s work bridges pediatric oncology and adult urologic oncology, offering insights that inform both clinical practice and future research into the mechanisms of therapy-induced cancers.
Research Focus
Key Achievements
Top Papers
- 1